Hani Babiker, MD

Experts discuss the importance of molecular profiling and testing in managing metastatic pancreatic cancer, highlighting advancements in treatment options.

Innovative drug development for pancreatic cancer focuses on KRAS and PRMT5 inhibitors, exploring combinations with chemotherapy for enhanced treatment efficacy.

Experts discuss the impact of NCCN guidelines on pancreatic cancer treatment, highlighting new therapies and future advancements in patient care.

Experts discuss the importance of communication and patient support in managing pancreatic cancer treatment and aligning care goals with patient needs.

Experts emphasize the importance of communication and patient support in managing pancreatic cancer, focusing on aligning treatment goals with personal preferences.

It seems there is no text provided for summarization. Please provide the text you'd like summarized, and I'll be happy to help!

Clinicians discuss managing diarrhea and nutritional support for pancreatic cancer patients, emphasizing the importance of a comprehensive care team.

Discover how NALIRIFOX offers a promising alternative to FOLFIRINOX, enhancing treatment options and reducing toxicities for pancreatic cancer patients.

Healthcare professionals discuss effective strategies for dose reduction in cancer treatment, emphasizing patient reassurance and maintaining treatment efficacy.

Explore strategies for adjusting chemotherapy dosages based on genetic mutations, enhancing patient safety and treatment efficacy in clinical practice.

Experts discuss the importance of real-world data in pancreatic cancer treatment, highlighting its impact on patient management and survival outcomes.

Experts discuss the importance of real-world data in pancreatic cancer treatment, highlighting its impact on patient management and survival outcomes.

Experts discuss the importance of real-world data in pancreatic cancer treatment, highlighting its impact on patient management and survival outcomes.

Experts discuss evolving treatment strategies for metastatic pancreatic cancer, comparing NALIRIFOX and FOLFIRINOX in first-line therapy decisions.

Experts discuss evolving treatment strategies for metastatic pancreatic cancer, comparing NALIRIFOX and FOLFIRINOX in first-line therapy decisions.